spacer
The Healthcare Sales & Marketing Network celebrates 28 years serving the medical sales & marketing community.Connecting Medical Sales Reps with MedTech/BioPharma Recruiters and Independent Reps with and New Product LinesConnecting Medical Sales Reps with MedTech/BioPharma Recruiters and Independent Reps with and New Product Lines

Searching News Database:  transdermal delivery 

 HSMN NewsFeed - 11 Feb 2020
Crescita Announces Positive Topline Results from Two Pivotal Phase 3 Clinical Studies for its Lead Pipeline Product in Patients with Plaque Psoriasis
Biopharmaceuticals Drug Delivery Dermatology
 HSMN NewsFeed - 20 Sep 2017
DURECT Appoints Dr. Myriam Theeuwes as Senior Vice President, Clinical Development
Biopharmaceuticals Personnel
 HSMN NewsFeed - 22 Jun 2017
DURECT Completes Enrollment in PERSIST, Phase 3 trial for POSIMIR(R)
Biopharmaceuticals
 HSMN NewsFeed - 8 Sep 2016
Zosano Appoints Georgia Erbez as Chief Business Officer
Biopharmaceuticals Drug Delivery Personnel
 HSMN NewsFeed - 30 Sep 2013
ProStrakan Launching SANCUSO (Granisetron Transdermal System) in European Union with 3M Drug Delivery Systems as Manufacturer
Biopharmaceuticals Drug Delivery Regulatory
 HSMN NewsFeed - 14 May 2013
Zosano Pharma, Inc. Appoints Nandan Oza as Chief Operations Officer
Biopharmaceuticals Drug Delivery Personnel
 HSMN NewsFeed - 9 Apr 2013
Zosano Pharma, Inc. Announces Key Strategic Hire
Biopharmaceuticals Drug Delivery Personnel
 HSMN NewsFeed - 25 Jan 2013
FDA Approves OXYTROL(R) FOR WOMEN, the First Over-the-Counter Treatment for Overactive Bladder in Women
Biopharmaceuticals Drug Delivery Urology FDA
 HSMN NewsFeed - 7 May 2012
New Phase III Data Show Agile Therapeutics' Low-Dose Patch Is Comparable to Combination Oral Contraceptive in a Comparator Study
Biopharmaceuticals Drug Delivery
 HSMN NewsFeed - 26 Sep 2011
Easton Pharmaceuticals Strengthens Sales Capabilities With Key Management Team Addition
Biopharmaceuticals Personnel
 HSMN NewsFeed - 14 Jun 2011
Easton Pharmaceuticals Announces The Appointment of John Easton as Interim Chief Executive Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 8 Apr 2011
Antares Pharma Announces FDA Acceptance of Anturol(R) NDA for Filing
Biopharmaceuticals Urology
 HSMN NewsFeed - 30 Aug 2010
Easton Pharmaceuticals Inc. Announces Experienced CFO Appointment to Management Team
Biopharmaceuticals Personnel
 HSMN NewsFeed - 1 Mar 2010
Transdel Pharmaceuticals Appoints Terry Nida as Chief Business Officer
Biopharmaceuticals Drug Delivery Personnel
 HSMN NewsFeed - 1 Dec 2009
MicroDose Therapeutx Acquires Epix Pharmaceuticals Portfolio of Compounds for Treatment of Chronic Constipation and Irritable Bowel Syndrome with Constipation (IBS-C)
Biopharmaceuticals Gastroenterology Acquisitions
 HSMN NewsFeed - 13 Oct 2009
Transdel Pharmaceuticals Appoints Dr. Joachim P.H. Schupp as Chief Medical Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 6 Oct 2009
Transdel Pharmaceuticals Announces Positive Phase 3 Study Results for Lead Topical Pain Drug Ketotransdel(R)
Biopharmaceuticals Drug Delivery
 HSMN NewsFeed - 7 Sep 2009
REGURIN(R) XL (trospium chloride) Once Daily Tablets Now Available in the UK for the Treatment of Overactive Bladder
Biopharmaceuticals Urology
 HSMN NewsFeed - 23 Jul 2009
Hisamitsu Pharmaceutical Co., Inc. Begins Tender Offer for All Outstanding Shares of Noven Pharmaceuticals, Inc.
Biopharmaceuticals Mergers & Acquisitions
 HSMN NewsFeed - 8 May 2009
Teikoku Pharma USA Acquires Travanti Pharma Inc.
Biopharmaceuticals Drug Delivery Acquisition
 HSMN NewsFeed - 8 Sep 2008
Zosano Pharma, Inc. Announces Appointment of Gail Schulze as Chair and CEO
Biopharmaceuticals Personnel
 HSMN NewsFeed - 12 Jun 2008
Lilly and TransPharma Medical Announce Licensing and Development Agreement
Biopharmaceuticals Drug Delivery Licensing
 HSMN NewsFeed - 24 Apr 2008
Transdel Pharmaceuticals Appoints Chief Medical Officer and Chief Operating Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 7 Feb 2008
Transdel Pharmaceuticals Submits to the FDA the Phase 3 Clinical Study of Ketotransdel(TM) for the Treatment of Acute Pain
Biopharmaceuticals Drug Delivery
 HSMN NewsFeed - 7 Jan 2008
Watson Announces Positive Results From Its Pivotal Study of Oxybutynin Topical Gel for the Treatment of Overactive Bladder
Biopharmaceuticals Urology
 HSMN NewsFeed - 7 Jan 2008
Antares Pharma Develops Novel Pen Injector under New Agreement with Teva Pharmaceuticals
Biopharmaceuticals Drug Delivery Licensing
 HSMN NewsFeed - 6 Nov 2007
Transdel Pharmaceuticals Appoints Mr. Anthony S. Thornley to Its Board of Directors
Biopharmaceuticals Personnel
 HSMN NewsFeed - 1 Nov 2007
Valeritas Announces Brand Name V-Go(TM) for Disposable Insulin Delivery Device
Devices Drug Delivery
 HSMN NewsFeed - 30 Oct 2007
New Therapies Emerging to Challenge Pain Management for Transdermal Patch Growth
Drug Delivery Biopharmaceuticals
 HSMN NewsFeed - 8 Oct 2007
Valeritas Hires Senior Account Management Industry Expert for the Launch of the h-Patch(TM) Disposable Insulin Delivery Device
Biopharmaceuticals Drug Delivery Personnel
 HSMN NewsFeed - 8 Oct 2007
Rotigotine Transdermal System Shows Significant Symptom Reduction and Tolerability in Patients with Restless Legs Syndrome
Biopharmaceuticals Neurology Drug Delivery
 HSMN NewsFeed - 8 Oct 2007
Neupro(R) (Rotigotine Transdermal System) Effective in Controlling Early Morning Motor Impairment and Generally Well-Tolerated for Long-Term Use in Patients with Parkinson's Disease
Biopharmaceuticals Neurology Drug Delivery
 HSMN NewsFeed - 25 Sep 2007
Valeritas Hires Trade and Distribution Industry Expert for the Launch of the h-Patch(TM) Disposable Insulin Delivery Device
Devices Drug Delivery Endocrinology Personnel
 HSMN NewsFeed - 23 Aug 2007
Antares Announces Initiation of Pivotal Trial of ANTUROL(TM) for the Treatment of Overactive Bladder
Biopharmaceuticals Urology
 HSMN NewsFeed - 25 Jul 2007
Antares Reaches Agreement with FDA on Special Protocol Assessment for Pivotal Trial of Anturol(TM)
Biopharmaceuticals Urology
 HSMN NewsFeed - 19 Jul 2007
Antares Announces Worldwide Development and License Agreement with Jazz Pharmaceuticals
Biopharmaceuticals Drug Delivery
 HSMN NewsFeed - 16 Jul 2007
UCB Announces the U.S. Launch of Neupro(R) (Rotigotine Transdermal System) for the Treatment of Early-Stage Parkinson's Disease
Biopharmaceuticals Neurology
 HSMN NewsFeed - 16 Jul 2007
SCHWARZ PHARMA and UCB, Inc. Announce U.S. Launch of Neupro(R) (Rotigotine Transdermal System) for the Treatment of Early-Stage Parkinson's Disease
Biopharmaceuticals Neurology
 HSMN NewsFeed - 22 Jun 2007
Encapsulation Systems Previews the U-Strip(TM) Insulin Patch, the Next Generation of Transdermal Drug Delivery for the Treatment of Diabetes
Biopharmaceuticals Drug Delivery Endocrinology
 HSMN NewsFeed - 10 May 2007
FDA Approves SCHWARZ PHARMA's Neupro(R) (Rotigotine Transdermal System) for the Treatment of Early-Stage Parkinson's Disease in USA
Biopharmaceuticals Drug Delivery Neurology FDA
 HSMN NewsFeed - 7 May 2007
Australian Nanotechnology Companies Set to Revolutionize Drug Delivery
Biopharmaceuticals Drug Delivery
 HSMN NewsFeed - 7 May 2007
BioSante Pharmaceuticals Signs Oral Contraceptive License with Pantarhei Bioscience
Biopharmaceuticals Licensing
 HSMN NewsFeed - 19 Apr 2007
Antares Pharma Announces Positive Results from Application Site Study for ANTUROL(R)
Biopharmaceuticals Drug Delivery
 HSMN NewsFeed - 16 Apr 2007
SCHWARZ PHARMA Announces Publication of Rotigotine Data for Advanced Parkinson's Disease in Neurology
Biopharmaceuticals Neurology
 HSMN NewsFeed - 10 Apr 2007
Brian M. Gallagher Joins Transport Pharmaceuticals' Board of Directors
Biopharmaceuticals Drug Delivery Personnel
 HSMN NewsFeed - 3 Apr 2007
Dermatrends Announces License Agreement With MINRAD International
Biopharmaceuticals Drug Delivery Licensing
 HSMN NewsFeed - 20 Mar 2007
Dharma Therapeutics Shows IDDS Is Effective in Reducing Pain Associated With Insertion of an Intravenous Catheter in Their Phase 2 Clinical Trial
Biopharmaceuticals Drug Delivery
 HSMN NewsFeed - 20 Feb 2007
Vyteris Announces Senior Staff Promotions
Devices Drug Delivery Personnel
 HSMN NewsFeed - 3 Jan 2007
SCHWARZ PHARMA Announces Publication of Rotigotine Data in Neurology
Biopharmaceuticals Drug Delivery Neurology
 HSMN NewsFeed - 3 Jan 2007
Sontra Enters Into Agreement for $600,000 Equity Investment
Devices Personnel
 HSMN NewsFeed - 2 Jan 2007
Antares ATD(TM) Formulation Enters Phase III Study
Biopharmaceuticals Drug Delivery
 HSMN NewsFeed - 27 Dec 2006
Sontra Medical Corporation Announces Plan to Cease Operations and to Voluntarily Delist From Nasdaq
Devices
 HSMN NewsFeed - 22 Dec 2006
Healthcare Marketing Expert Joins Valeritas as Vice President of Marketing & Marketing Operations
Devices Drug Delivery Personnel
 HSMN NewsFeed - 18 Dec 2006
Antares Receives First FDA Approval of ATD(TM) Gel Platform
Biopharmaceuticals FDA
 HSMN NewsFeed - 26 Oct 2006
DAYTRANA(TM) (methylphenidate transdermal system) Provides Individualized Symptom Management
Biopharmaceuticals
 HSMN NewsFeed - 4 Oct 2006
Antares Pharma to Supply Teva with Innovative Needle-Free Injection System
Biopharmaceuticals
 HSMN NewsFeed - 13 Sep 2006
NuPathe Closes $15 Million Financing
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 12 Sep 2006
John Timberlake Joins Valeritas from sanofi-aventis as Executive Vice President and General Manager of Metabolics
Biopharmaceuticals Personnel
 HSMN NewsFeed - 18 Jul 2006
Antares Pharma Announces Licensing Agreement with Teva for Novel Injector Device
Biopharmaceuticals Devices Drug Delivery Licensing
 HSMN NewsFeed - 29 Jun 2006
Noven Confirms Availability of Daytrana(TM) Methylphenidate Transdermal System
Biopharmaceuticals
 HSMN NewsFeed - 29 Jun 2006
Shire's DAYTRANA(TM), First Transdermal Medication for Treatment of Attention Deficit Hyperactivity Disorder (ADHD) in Children, Now Available in Pharmacies
Biopharmaceuticals Drug Delivery
 HSMN NewsFeed - 26 Jun 2006
Sontra Medical Signs Distribution Agreement with Korean Distributor JOYMG for SonoPrep(R) Skin Permeation System
Devices Drug Delivery Distribution
 HSMN NewsFeed - 26 Jun 2006
Antares Reports On End of Phase II Meeting with FDA for Anturol(TM)
Biopharmaceuticals Urology
 HSMN NewsFeed - 25 May 2006
Significant ADHD Symptom Control With Shorter DAYTRANA(TM) (methylphenidate transdermal system) Wear Time
Biopharmaceuticals
 HSMN NewsFeed - 24 May 2006
Positive Study Results for DAYTRANA(TM) (methylphenidate transdermal system) Presented at a Major Medical Meeting
Biopharmaceuticals Drug Delivery
 HSMN NewsFeed - 9 May 2006
Sontra Medical Introduces Generation 2.0 SonoPrep(R) Skin Permeation Device
Devices Drug Delivery
 HSMN NewsFeed - 5 May 2006
VIVUS Announces Positive Phase 3 Clinical Trial Results for Evamist(TM) - The First Transdermal Spray for the Treatment of Menopausal Symptoms
Biopharmaceuticals Drug Delivery
Return to NewsFeed  

 Additional items found! 87

Members: click here for search results from The HSMN Archive (password required)
Members Archive contains 87 additional stories matching:
transdermal delivery
(Password required)
FindReps - screen and connect with rep candidates anonymously, in real time.

FindReps: Screen and connect with Medical Sales Rep candidates (Direct Reps and Independents) – anonymously, in real time.


RepJobs - Job Opportunities for Direct Sales Reps and New Product Lines for Independents!

RepJobs: Job Opportunities for Direct Sales Reps and New Product Lines for Independents!